About University of Michigan Scleroderma Program
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of Michigan Scleroderma Program
During the past decade, University of Michigan Scleroderma Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Scleroderma Program"
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at University of Michigan Scleroderma Program
According to Clinical.Site data, the most researched conditions in "University of Michigan Scleroderma Program" are
"Systemic Sclerosis" (6 trials), "Pulmonary Arterial Hypertension" (2 trials), "Pulmonary Hypertension" (2 trials), "Scleroderma" (2 trials) and "Ulcers" (1 trials). Many other conditions were trialed in "University of Michigan Scleroderma Program" in a lesser frequency.
Clinical Trials Intervention Types at University of Michigan Scleroderma Program
Most popular intervention types in "University of Michigan Scleroderma Program" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "treprostinil diethanolamine" (3 trials), "placebo" (2 trials), "macitentan 10mg" (1 trials) and "macitentan 3mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Michigan Scleroderma Program
The vast majority of trials in "University of Michigan Scleroderma Program" are
6 trials for "All" genders.
Clinical Trials Status at University of Michigan Scleroderma Program
Currently, there are NaN active trials in "University of Michigan Scleroderma Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in University of Michigan Scleroderma Program,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Michigan Scleroderma Program, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".